Tech Company Financing Transactions
NuMe Health Funding Round
On 5/16/2012, NuMe Health secured $1.5 million in Series A financing from BVM Capital and private investors.
Transaction Overview
Company Name
Announced On
5/16/2012
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Series A
Investors
BVM Capital (Lead Investor) (Ross Barrett)
Proceeds Purpose
The company intends to use the funds to advance NM504 towards commercialization, including developing the initial format for its first consumer product, completing the pilot clinical trial and preparing for an initial direct-to-consumer launch.
Company Information
Company Status
Out of Business
Industry
Healthcare IT
Mailing Address
1441 Canal St.
New Orleans, LA 70112
USA
New Orleans, LA 70112
USA
Phone
Website
Email Address
Overview
NuMe Health is developing evidence-based prebiotic products designed to alter bacterial populations in the GI tract to prevent and manage serious health conditions. NuMe's initial products and research are focusing on pre-diabetes, diabetes and unhealthy body weight.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dean Stull
Chief Scientific Officer
Mark Heiman
Browse more venture capital transactions:
Prev: 5/16/2012: Simplee venture capital transaction
Next: 5/16/2012: Ambra Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs